Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Cystitis 1

Interventions

Gemcitabine 7Cystectomy 5Cisplatin 5durvalumab 4Neoadjuvant Therapy 4Mitomycin 4atezolizumab 3Transurethral Resection of Bladder 3Nivolumab 3Epirubicin 3Chemoradiotherapy 3BCG Vaccine 3Anesthesia, Spinal 3tislelizumab 2disitamab vedotin 2catumaxomab 2Vitamin E 2Urinary Diversion 2Sunitinib 2Selenium 2Robotic Surgical Procedures 2Multiparametric Magnetic Resonance Imaging 2Magnetic Resonance Imaging 2Immunohistochemistry 2Fentanyl 2Docetaxel 2Diathermy 2Cystoscopy 2Chemoprevention 2BCG Connaught 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Urinary Bladder Neoplasms × lornoxicam × Clear all
NCT03038321 2017-05-23

Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?

Mansoura University

Phase 4 Unknown
150 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Cystitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡